Causes of Mortality in Patients with Chronic Cerebral Ischemia in Multifocal Atherosclerosis
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Abstract
The objective: to evaluate the causes of death in patients with chronic brain ischemia with multifocal atherosclerosis.
Materials and methods. The study included 137 patients aged 40 to 84 years with chronic brain ischemia (CBI) against the background of multifocal atherosclerosis, which were divided into three clinical groups depending on the localization of vascular pool affection by stenosic atherosclerosis. The causes of death for 10 years were analyzed.
Results. In the general group of investigated causes of death comorbid pathology (myocardial infarction, CHD with hypertensive disease) prevailed – 66,7 % of cases (30 among 45 dead) at p<0,01. Strokes of various types amounted to 20.0 % of cases (9 among 45 dead) and polymorbid pathology – 13.3 % (6 among 45 dead). The age of those who died between 50 and 60 years was 8.9 %, between 60 and 70 years old – 22.2 % and over 70 years old – 68.9 % of cases. Among the causes of death in all clinical groups, comorbid pathology significantly prevailed over stroke: in the first group – in 16.7% and 3.3% respectively, in the second group – in 24.1 % and 5.7 % respectively, and in the third group – in 20.0 % of cases of comorbid pathology without strokes. Mortality rate in chronic course of the disease was 47.8 %, in CBI with TIA – 13.4 %, in CBI with another stroke in the history – 30.5%, in CBI with repeated strokes in the history – 35.0 %. Strokes among the causes of death were more often established in the group of patients with CBI with recurrent strokes.
Conclusions. Comorbid pathology as a modifiable factor, irrespective of the combination of vascular pools affected by atherosclerosis and the nature of the CBI flow, prevailed among the causes of death in patients with CBI in the background of multifocal atherosclerosis. Strokes of various types were the second leading cause of death in patients with CBI. In the analysis of mortality among patients with different types of CBI course was established reliably high its frequency in the group of persons with chronic course of disease without acute episodes of ischemia in the history with high rate of mortality from comorbid pathology.##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Абрагамович О.О., Фаюра О.П., Абрагамович У.О. Коморбідність: сучасний погляд на проблему; класифікація // Львівський клінічний вісник. – 2006. – № 1 (13). – С. 31–39.
Зозуля А.І., Слабкий Г.О., Зозуля І.С. Проблеми, які стоять перед дослідниками щодо цереброваскулярних хвороб у цілому та інсульту зокрема. Український медичний часопис. 2014;5(103 – IX/X):112-120 www.umj.com.ua
Наказ МОЗ України від 13.06.2016 № 564 «Про затвердження та впровадження медико-технологічних документів зі стандартизації медичної допомоги в частині профілактики серцево-судинних захворювань».
Овсянникова Н.А., Арьев А.Л., Жулев Н.М. Цереброваскулярные заболевания и коморбидные состояния – новое представление проблемы // Вестник Санкт-Петербургского университета. – 2011. – Сер. 11, Вып. 2. – С. 147–154.
Самородская И.В., Андреев Е.М. и соавт. Показатели смертности населения старше 50 лет от цереброваскулярных болезней за 15-летний период в России и США // Неврология, нейропсихиатрия, психосоматика. – 2017. – № 9 (2). – С. 15–24.
Таблиці народжуваності, смертності та середньої очікуваної тривалості життя за 2018 рік. Статистичний збірник державної служби статистики України. Київ-2019. www.ukrstat.gov.ua
Arnett et al. 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease. Journal of the American college of cardiology (JACC) Vol. 74, NO. 10, 2019. https://doi.org/10.1016/j.jacc.2019.03.010
Baligh Essam et al. The impact of vascular risk factors multiplicity on severity of carotid atherosclerosis – а retrospective analysis of 1969 Egyptian subjects. World Journal of Cardiovascular Diseases. 2013;3:414-418. http://dx.doi.org/10.4236/wjcd.2013.36065
Dzyak L.А., Rosytska О.А. Сomorbidity profile in chronic brain ischemia on the background of multifocal atherosclerosis. Medicni perspektivi. 2019;24(4):74-83
Schafer et al. Multimorbidity patterns and 5-year overall mortality: results from a claims data-based observational study. Journal of Comorbidity. 2018; Volume 8:1–13. DOI: 10.1177/2235042X18816588
Wardlaw JoannaM. et al. What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. Journal of the American Heart Association. 2015;4(6):e001140. DOI: 10.1161/JAHA.114.001140
